Literature DB >> 8721540

The implications of drug resistance for strategies of combination antiviral chemotherapy.

D D Richman1.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8721540     DOI： 10.1016/0166-3542(95)00911-6

Source DB:  PubMed          Journal:  Antiviral Res        ISSN： 0166-3542            Impact factor:   5.970


× No keyword cloud information.
  10 in total

1.  Costs versus benefits: best possible and best practical treatment regimens for HIV.

Authors:  O Krakovska; L M Wahl
Journal:  J Math Biol       Date:  2007-01-05       Impact factor: 2.259

Review 2.  HIV evolution and escape.

Authors:  Douglas D Richman; Susan J Little; Davey M Smith; Terri Wrin; Christos Petropoulos; Joseph K Wong
Journal:  Trans Am Clin Climatol Assoc       Date:  2004

3.  Selective intracellular activation of a novel prodrug of the human immunodeficiency virus reverse transcriptase inhibitor tenofovir leads to preferential distribution and accumulation in lymphatic tissue.

Authors:  William A Lee; Gong-Xin He; Eugene Eisenberg; Tomas Cihlar; Swami Swaminathan; Andrew Mulato; Kenneth C Cundy
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

Review 4.  The role of viral dynamics in the pathogenesis of HIV disease and implications for antiviral therapy.

Authors:  D V Havlir; D D Richman
Journal:  Springer Semin Immunopathol       Date:  1997

5.  SAR Based Optimization of a 4-Quinoline Carboxylic Acid Analog with Potent Anti-Viral Activity.

Authors:  Priyabrata Das; Xiaoyi Deng; Liang Zhang; Michael G Roth; Beatriz M A Fontoura; Margaret A Phillips; Jef K De Brabander
Journal:  ACS Med Chem Lett       Date:  2013-06-13       Impact factor: 4.345

6.  Antiviral efficacy of adefovir dipivoxil versus lamivudine in patients with chronic hepatitis B sequentially treated with lamivudine and adefovir due to lamivudine resistance.

Authors:  Yeon Seok Seo; Ji Hoon Kim; Jong Eun Yeon; Jong-Jae Park; Jae-Seon Kim; Kwan Soo Byun; Young-Tae Bak; Chang Hong Lee
Journal:  World J Gastroenterol       Date:  2007-08-14       Impact factor: 5.742

7.  Lamivudine monotherapy in chronic hepatitis B patients from the Indian subcontinent: antiviral resistance mutations and predictive factors of treatment response.

Authors:  Ashrafali Mohamed Ismail; Prasanna Samuel; Jeyamani Ramachandran; Chundamannil Eapen Eapen; Rajesh Kannangai; Priya Abraham
Journal:  Mol Diagn Ther       Date:  2014-02       Impact factor: 4.074

8.  Potent neutralization of influenza A virus by a single-domain antibody blocking M2 ion channel protein.

Authors:  Guowei Wei; Weixu Meng; Haijiang Guo; Weiqi Pan; Jinsong Liu; Tao Peng; Ling Chen; Chang-You Chen
Journal:  PLoS One       Date:  2011-12-02       Impact factor: 3.240

Review 9.  Viral and cellular RNA helicases as antiviral targets.

Authors:  Ann D Kwong; B Govinda Rao; Kuan-Teh Jeang
Journal:  Nat Rev Drug Discov       Date:  2005-10       Impact factor: 84.694

Review 10.  Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade.

Authors:  Hyung Joon Yim; Seong Gyu Hwang
Journal:  Clin Mol Hepatol       Date:  2013-09-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.